scispace - formally typeset
Search or ask a question

Showing papers by "Guillermo Torre-Amione published in 2017"

Journal Article•DOI•
Myocardial Recovery in Patients With Systolic Heart Failure and Autoantibodies Against β1-Adrenergic Receptors

[...]

Yuji Nagatomo1, Dennis M. McNamara2, Jeffrey D. Alexis3, Leslie T. Cooper4, G. William Dec5, Daniel F. Pauly6, Richard Sheppard7, Randall C. Starling1, W.H. Wilson Tang1, Karen Janosko, Charles F. McTiernan, Barry London, Karen Hanley-Yanez, John Gorcsan, Hidekazu Tanaka, Mathew Suffoletto, Cynthia Oblak, Annette McNallan, Lu Anne Koenig, Paul J. Mather, Natalie Pierson, Sharon Rubin, Yanique Bell, Alicia Ervin, John P. Boehmer8, Patricia Frey, Jeffrey D. Alexis9, Janice Schrack, Pam LaDuke, Guillermo Torre-Amione, Jeannie Arredondo, Pamela C. Smith, Stephanie Fuoco, Ilan S. Wittstein, Elayne Breton, Vinay Thohan, Deborah J. Wesley, Diane Cocca-Spofford, David W. Markham, Lynn Fernandez, Colleen H. Debes, Mark J. Zucker, Laura Adams, Peter Liu, Judith Renton, Jagat Narula, Byron Allen, Elizabeth Westberg •
Cleveland Clinic1, University of Pittsburgh2, University of Rochester3, Mayo Clinic4, Harvard University5, Truman Medical Center6, McGill University7, Pennsylvania State University8, University of Rochester Medical Center9
28 Feb 2017-Journal of the American College of Cardiology
TL;DR: In patients with high New York Heart Association functional class (III or IV) at baseline, the IgG3 group had a lower incidence of the composite endpoint of all-cause death, cardiac transplantation, and hospitalization due to heart failure, whereas the non-IgG3 groups had the highest incidence ofthe composite endpoint.

25 citations

Journal Article•DOI•
098 - Mitochondrial Hyperacetylation Contributes with Ventricular Dysfunction as Consequence of SIRT3 Deficiency in Obesity and Metabolic Syndrome

[...]

Jose Morales, Elena C. Castillo, Christian Silva-Platas, Guillermo Torre-Amione, Keith A. Youker, Gerardo García-Rivas 
01 Aug 2017-Journal of Cardiac Failure

1 citations